AD Pharma

United States Biosimilars Market 2017-2022 growth, trends and demands research available in new report : Global QYResearch

Press Release   •   Feb 24, 2017 10:41 EET

This report studies sales (consumption) of United States Biosimilars Market 2017, focuses on the top players, with sales, price, revenue and market share for each player, covering

Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy’s Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Request more information at http://globalqyresearch.com/download-sample/175517 

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II

Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into
Application 1
Application 2

View full report at http://globalqyresearch.com/united-states-biosimilars-market-report-2017

Table of Contents

United States Biosimilars Market Report 2017
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Type I
1.2.2 Type II
1.3 Application of Biosimilars
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilars (2012-2022)
1.4.1 United States Biosimilars Sales and Growth Rate (2012-2022)
1.4.2 United States Biosimilars Revenue and Growth Rate (2012-2022)

2 United States Biosimilars Competition by Manufacturers
2.1 United States Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biosimilars Market Competitive Situation and Trends
2.4.1 Biosimilars Market Concentration Rate
2.4.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Biosimilars Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Biosimilars Sales and Market Share by States (2012-2017)
3.2 United States Biosimilars Revenue and Market Share by States (2012-2017)
3.3 United States Biosimilars Price by States (2012-2017)

4 United States Biosimilars Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Biosimilars Sales and Market Share by Type (2012-2017)
4.2 United States Biosimilars Revenue and Market Share by Type (2012-2017)
4.3 United States Biosimilars Price by Type (2012-2017)
4.4 United States Biosimilars Sales Growth Rate by Type (2012-2017)

5 United States Biosimilars Sales (Volume) by Application (2012-2017)
5.1 United States Biosimilars Sales and Market Share by Application (2012-2017)
5.2 United States Biosimilars Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Biosimilars Manufacturers Profiles/Analysis
6.1 Sandoz International
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biosimilars Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sandoz International Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Hospira
6.2.2 Biosimilars Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Hospira Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceutical
6.3.2 Biosimilars Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Dr. Reddy's Laboratories
6.4.2 Biosimilars Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biocon
6.5.2 Biosimilars Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Mylan
6.6.2 Biosimilars Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Amgen
6.7.2 Biosimilars Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Celltrion
6.8.2 Biosimilars Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Roche Diagnostics
6.9.2 Biosimilars Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Roche Diagnostics Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Merck KGaA
6.10.2 Biosimilars Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Biosimilars Market Forecast (2017-2022)
11.1 United States Biosimilars Sales, Revenue Forecast (2017-2022)
11.2 United States Biosimilars Sales Forecast by Type (2017-2022)
11.3 United States Biosimilars Sales Forecast by Application (2017-2022)
11.4 Biosimilars Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/175517

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch